These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 12468639)
1. Effects of GnRH analogues, 'add-back' steroid therapy, antiestrogen and antiprogestins on leiomyoma and myometrial smooth muscle cell growth and transforming growth factor-beta expression. Chegini N; Ma C; Tang XM; Williams RS Mol Hum Reprod; 2002 Dec; 8(12):1071-8. PubMed ID: 12468639 [TBL] [Abstract][Full Text] [Related]
2. Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro. Chegini N; Rong H; Dou Q; Kipersztok S; Williams RS J Clin Endocrinol Metab; 1996 Sep; 81(9):3215-21. PubMed ID: 8784072 [TBL] [Abstract][Full Text] [Related]
3. Differential expression, regulation, and induction of Smads, transforming growth factor-beta signal transduction pathway in leiomyoma, and myometrial smooth muscle cells and alteration by gonadotropin-releasing hormone analog. Xu J; Luo X; Chegini N J Clin Endocrinol Metab; 2003 Mar; 88(3):1350-61. PubMed ID: 12629129 [TBL] [Abstract][Full Text] [Related]
4. The expression of Abl interactor 2 in leiomyoma and myometrium and regulation by GnRH analogue and transforming growth factor-beta. Luo X; Levens E; Williams RS; Chegini N Hum Reprod; 2006 Jun; 21(6):1380-6. PubMed ID: 16488906 [TBL] [Abstract][Full Text] [Related]
5. Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids. Pan Q; Luo X; Chegini N J Cell Mol Med; 2008; 12(1):227-40. PubMed ID: 18182067 [TBL] [Abstract][Full Text] [Related]
6. Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin-releasing hormone analogue therapy and TGF-beta through Smad and MAPK-mediated signalling. Levens E; Luo X; Ding L; Williams RS; Chegini N Mol Hum Reprod; 2005 Jul; 11(7):489-94. PubMed ID: 16123076 [TBL] [Abstract][Full Text] [Related]
8. Antiprogestins suppress basal and activin-stimulated follicle-stimulating hormone secretion in an estrogen-dependent manner. Szabo M; Kilen SM; Saberi S; Ringstrom SJ; Schwartz NB Endocrinology; 1998 May; 139(5):2223-8. PubMed ID: 9564826 [TBL] [Abstract][Full Text] [Related]
9. CCNs, fibulin-1C and S100A4 expression in leiomyoma and myometrium: inverse association with TGF-beta and regulation by TGF-beta in leiomyoma and myometrial smooth muscle cells. Luo X; Ding L; Chegini N Mol Hum Reprod; 2006 Apr; 12(4):245-56. PubMed ID: 16571622 [TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor-beta. Luo X; Ding L; Xu J; Chegini N Endocrinology; 2005 Mar; 146(3):1097-118. PubMed ID: 15604209 [TBL] [Abstract][Full Text] [Related]
11. Gonadotropin releasing hormone analogue (GnRHa) alters the expression and activation of Smad in human endometrial epithelial and stromal cells. Luo X; Xu J; Chegini N Reprod Biol Endocrinol; 2003 Dec; 1():125. PubMed ID: 14678567 [TBL] [Abstract][Full Text] [Related]
12. Gonadotropin releasing hormone and transforming growth factor beta activate mitogen-activated protein kinase/extracellularly regulated kinase and differentially regulate fibronectin, type I collagen, and plasminogen activator inhibitor-1 expression in leiomyoma and myometrial smooth muscle cells. Ding L; Xu J; Luo X; Chegini N J Clin Endocrinol Metab; 2004 Nov; 89(11):5549-57. PubMed ID: 15531510 [TBL] [Abstract][Full Text] [Related]
13. Leiomyoma and myometrial gene expression profiles and their responses to gonadotropin-releasing hormone analog therapy. Luo X; Ding L; Xu J; Williams RS; Chegini N Endocrinology; 2005 Mar; 146(3):1074-96. PubMed ID: 15604208 [TBL] [Abstract][Full Text] [Related]
14. microRNA 21: response to hormonal therapies and regulatory function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells. Pan Q; Luo X; Chegini N Mol Hum Reprod; 2010 Mar; 16(3):215-27. PubMed ID: 19906824 [TBL] [Abstract][Full Text] [Related]
16. Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta. Lee BS; Nowak RA J Clin Endocrinol Metab; 2001 Feb; 86(2):913-20. PubMed ID: 11158066 [TBL] [Abstract][Full Text] [Related]
17. Expression, menstrual cycle-dependent activation, and bimodal mitogenic effect of transforming growth factor-beta1 in human myometrium and leiomyoma. Arici A; Sozen I Am J Obstet Gynecol; 2003 Jan; 188(1):76-83. PubMed ID: 12548199 [TBL] [Abstract][Full Text] [Related]
18. Gonadotropin-releasing hormone (GnRH) agonist leuprolide acetate and GnRH antagonist cetrorelix acetate directly inhibit leiomyoma extracellular matrix production. Britten JL; Malik M; Levy G; Mendoza M; Catherino WH Fertil Steril; 2012 Nov; 98(5):1299-307. PubMed ID: 22901846 [TBL] [Abstract][Full Text] [Related]